Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticlePediatric Rheumatology

National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000–2009

Andrea M. Knight, Pamela F. Weiss, Knashawn H. Morales and Ron Keren
The Journal of Rheumatology March 2014, 41 (3) 539-546; DOI: https://doi.org/10.3899/jrheum.130592
Andrea M. Knight
From the Division of Rheumatology, the Division of General Pediatrics, and the Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia; the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: knightan@email.chop.edu
Pamela F. Weiss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knashawn H. Morales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ron Keren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Inpatient mortality for children and adolescents with a diagnosis of systemic lupus erythematosus (SLE) showed a statistically significant decrease over the years of study (OR 0.95, 95% CI 0.900–0.998, p = 0.04). Mortality for those with SLE nephritis also showed a statistically significant decrease (OR 0.93, 95% CI 0.88–0.99, p = 0.01). Mortality for all other KID hospitalizations showed a statistically significant but very minor decrease (OR 0.97, 95% CI 0.96–0.97, p < 0.001). The difference in rate of mortality decrease for hospitalizations with SLE diagnosis versus those without a SLE diagnosis was not statistically significant. Error bars indicate standard error; the error bars for the group of hospitalizations without an SLE diagnosis are so small that they are barely visible on the graph. KID: US Kids’ Inpatient Database.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    A. The most common 75% of billed procedures during hospitalization for systemic lupus erythematosus are shown. GI: gastrointestinal; CT: computed tomography; MRI: magnetic resonance imaging; EEG: electroencephalography. B. Temporal trends for the 5 most commonly billed hospital procedures (comprising over 40% of all procedures) are shown. The associated p values for trend are medication infusion (p = 0.20), dialysis (p = 0.01), blood transfusion (p < 0.001), vascular catheterization (p = 0.002), and renal biopsy (p = 0.74).

Tables

  • Figures
    • View popup
    Table 1.

    Demographics for hospitalizations with a diagnosis of SLE.

    n = 26,903 for All Yearsn (%)
    Patient-specific factors
      Age, yrs
        2–122337 (8.7)
        12–1712,379 (46.0)
        18–2012,187 (45.3)
      Female*22,814 (84.8)
      Race/ethnicity*
        White5140 (19.1)
        Black8853 (32.9)
        Hispanic5902 (21.9)
        Other2733 (10.2)
      Primary payer*
        Medicaid12,268 (45.6)
        Private10,411 (38.7)
        Other4171 (15.5)
      SLE nephritis
        No11,705 (43.5)
        Yes15,198 (56.5)
    Hospital-specific factors
      Location*
        Urban24,858 (92.4)
        Rural1025 (3.8)
      Region
        Northeast5165 (19.2)
        Midwest4246 (15.8)
        South10,478 (38.9)
        West7014 (26.1)
    Teaching status*
      Teaching20,608 (76.6)
      Non-teaching5281 (19.6)
    Type*
      Children’s Hospital14,958 (55.6)
      General Hospital9990 (37.1)
    • ↵* The percentages for these categories do not add up to 100% because of missing demographic data, as follows: sex 0.3%, race/ethnicity 15.9%, primary payer 0.2%, location 3.8%, teaching status 3.8%, hospital type 7.3%. SLE: systemic lupus erythematosus.

    • View popup
    Table 2.

    Temporal trends in SLE hospitalization rate, mortality, and LOS.

    YearDischarges, n (95% CI)Hospitalization Rate* (95% CI)Mortality, % (95% CI)Mean LOS, days (95% CI)
    All yrs26,903 (23,802–30,005)8.6 (7.6–9.6)1.0 (0.8–1.1)5.9 (5.6–6.2)
    20005962 (5096–6827)7.7 (6.6–8.8)1.0 (0.7–1.4)5.6 (5.2–6.1)
    20036701 (5844–7559)8.6 (7.6–9.7)1.2 (0.8–1.5)6.1 (5.7–6.5)
    20067344 (6416–8273)9.3 (8.2–10.5)1.2 (0.9–1.5)6.3 (5.8–6.8)
    20096896 (6021–7770)8.7 (7.6–9.7)0.6 (0.4–0.8)5.7 (5.3–6.0)
    p value for trend**—0.140.040.45
    • ↵* SLE hospitalizations per 100,000 children in population aged 2 to 21 years, based on population estimates from US Census data.

    • ↵** Outcomes evaluated for temporal trend using multivariable regression to adjust for patient and hospital-specific demographic variables (with the exception of hospitalization rate, which was evaluated by univariable regression). SLE: systemic lupus erythematosus; LOS: length of stay.

    • View popup
    Table 3.

    Risk factors for inpatient mortality and LOS for SLE hospitalizations.

    Risk FactorMortality, OR (95% CI)LOS, RR (95% CI)
    Nephritis
      No——
      Yes2.71 (1.74–4.23)***1.30 (1.21–1.40)***
    Age, yrs
      2–12——
      12–171.42 (0.58–3.48)0.92 (0.81–1.04)
      18–202.85 (1.21–6.71)*1.06 (0.93–1.20)
    Sex
      Female——
      Male1.51 (0.99–2.29)1.03 (0.94–1.14)
    Race
      White——
      Black2.01 (1.12–3.62)*1.09 (1.00–1.20)
      Hispanic1.39 (0.73–2.64)1.07 (0.97–1.18)
      Other1.88 (0.94–3.75)1.14 (1.001–1.30)*
    Payer
      Medicaid——
      Private0.89 (0.59–1.34)0.88 (0.82–0.94)***
      Other1.01 (0.65–1.58)0.90 (0.82–0.999)*
    Location
      Rural——
      Urban0.98 (0.28–3.42)1.33 (1.16–1.53)***
    Region
      Northeast——
      Midwest0.81 (0.34–1.95)1.08 (0.92–1.28)
      South2.03 (1.23–3.36)**1.06 (0.92–1.21)
      West1.77 (0.98–3.20)1.11 (0.93–1.32)
    Teaching
      No——
      Yes1.06 (0.60–1.87)1.10 (1.01–1.20)*
    Type
      General——
      Children’s0.95 (0.59–1.52)1.05 (0.95–1.17)
    • Shown are OR and relative risks (RR) for risk factors included in the multivariable regressions for the main outcomes. The covariates included in the multivariable regressions were calendar year, presence of SLE nephritis, age group, sex, race/ethnicity, primary payer, hospital location, hospital region, hospital teaching status, and hospital type. Reference groups are denoted by “—”. Significance for p values is

    • ↵* p < 0.05,

    • ↵** p < 0.01,

    • ↵*** p < 0.001. SLE: systemic lupus erythematosus; LOS: length of stay.

    • View popup
    APPENDIX 1.

    ICD-9-CM codes used to define SLE nephritis. SLE diagnosis with ICD-9-CM = 710.0 in any position, plus one of the following codes in any position.

    ICD-9-CM Diagnosis Codes
      Nephritis580.0, 580.4, 580.8, 580.81, 580.89, 580.9, 581.0, 581.1, 581.2, 581.3, 581.8, 581.81, 581.89, 581.9, 582.0, 582.1, 582.2, 582.4, 582.8, 582.81, 582.89, 582.9, 583.0, 583.1, 583.2, 583.4, 583.6, 583.7, 583.8, 583.81, 583.89, 583.9
      Chronic kidney disease585, 585.1, 585.2, 585.3, 585.4, 283.11, 403.00, 403.10, 403.90, 404.00, 404.10, 404.90, 404.01, 404.11, 404.91, 587, 588.8, 588.9, 642.1, 642.2, 794.4
      Dialysisv56.0, v56.8, v45.11, v56.1, v56.2, v56.3, v45.12, 792.5, v45.1, v56.31, v56.32
      Kidney transplantv42.0, 996.81
      Acute kidney failure584, 584.5, 584.6, 584.7, 584.8, 584.9
      Endstage kidney disease585.5, 585.6, 585.9, 586, 403.01, 403.11, 403.91, 404.02, 404.12, 404.92, 404.03, 404.13, 404.93
    ICD-9-CM Procedure Codes
      Dialysis39.95, 54.98, 39.93, 39.94, 39.42, 39.27
      Kidney transplant55.69, 55.53, 55.52, 55.51, 55.54
      Kidney biopsy55.23, 55.24, 55.39, 55.21
    • ICD-9-CM: International Classification of Diseases, 9th revision, clinical modification; SLE: systemic lupus erythematosus.

    • View popup
    APPENDIX 2.

    ICD-9 code groupings for procedure categories.

    Procedure CategoryICD-9-CM Procedure Codes
    Medication infusion9971, 9929, 9928, 9923, 9925, 9921, 9914, 9918, 9919, 9910
    Dialysis5498, 3995, 3994, 3993, 3942, 3927
    Blood transfusion9900–9909
    Vascular catheterization3891, 3892, 3893
    Renal biopsy5523, 5524
    Diagnostic ultrasound8872, 8873, 8875, 8877–8879, 0023
    Obstetric procedures740–742, 7499, 7301, 7309, 731, 734, 7351, 7359, 7531–7535, 7538, 7550–7552, 7561, 7562, 7569
    Intubation/ventilation9390, 9604, 9671, 9672
    Spinal tap331
    GI endoscopy/biopsy4223, 4224, 4414, 4513, 4514, 4516, 4523–4525
    CT scan8703, 8741, 8801, 8771 0031, 8838
    Pericardiocardial/thoracic/abdominal centesis3404, 3409, 3491, 370, 5491
    MRI8891–8895, 8897
    Angiography8851, 8849, 8847, 8843, 8841, 8852–8857, 3721–3723
    Physical/occupational therapy9339, 9322, 9311, 9383, 9381, 9375
    Bone marrow biopsy4131
    Bronchoscopy3322–3324, 3326, 3327
    Enteral/parenteral nutrition966, 9915
    Plasmapheresis9971–9974
    EEG8914
    • ICD-9-CM: International Classification of Diseases, 9th revision, clinical modification; GI: gastrointestinal; CT: computed tomography; MRI: magnetic resonance imaging; EEG: electroencephalography.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000–2009
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000–2009
Andrea M. Knight, Pamela F. Weiss, Knashawn H. Morales, Ron Keren
The Journal of Rheumatology Mar 2014, 41 (3) 539-546; DOI: 10.3899/jrheum.130592

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000–2009
Andrea M. Knight, Pamela F. Weiss, Knashawn H. Morales, Ron Keren
The Journal of Rheumatology Mar 2014, 41 (3) 539-546; DOI: 10.3899/jrheum.130592
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1.
    • APPENDIX 2.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

SYSTEMIC LUPUS ERYTHEMATOSUS
PEDIATRIC
HOSPITALIZATION
MORTALITY
LENGTH OF STAY

Related Articles

Cited By...

More in this TOC Section

  • Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis
  • Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference
  • Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry
Show more Pediatric Rheumatology

Similar Articles

Keywords

  • systemic lupus erythematosus
  • PEDIATRIC
  • hospitalization
  • mortality
  • LENGTH OF STAY

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire